TY  - CHAP
M1  - Book, Section
TI  - Deep Venous Thromboembolism
A1  - Sharma, Sriganesh B.
A1  - Obi, Andrea
A2  - Nazzal, Munier
A2  - Blebea, John
A2  - Osman, Mohamed F.
PY  - 2024
T2  - Vascular and Endovascular Surgery: Clinical Diagnosis and Management
AB  - Venous  thromboembolism  (VTE),  which  includes  both  deep  venous  thrombosis  (DVT)  and  pulmonary  embolism  (PE),  represents  one  of  the  most  common  preventable  causes  of  hospital  death  and  is  associated  with  substantial  long-term  morbidity  and  mortality.  The  incidence  of  DVT  exceeds  250,000  patients  a  year  while  more  than  200,000  patients  a  year  develop  PE.1,2  The  total  incidence  of  VTE  is  estimated  between  300,000  and  600,000  individuals  in  the  United  States  per  year.3  The  widespread  impact  of  VTE  on  healthcare  spending  ranges  in  the  order  of  billions  of  dollars.4  Therefore,  the  incidence,  prevalence,  cost,  morbidity,  and  mortality  from  VTE  represent  a  significant  public  health  burden.  As  such,  understanding  the  underlying  risk  factors,  diagnostic  approaches,  and  factors  that  affect  prophylaxis  and  treatment  of  DVTs  and  PEs  is  paramount.  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/24
UR  - accesssurgery.mhmedical.com/content.aspx?aid=1200676925
ER  -